NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,195,578 | +59.7% | 247,469 | +58.2% | 0.04% | +32.1% |
Q2 2023 | $15,780,887 | +23.3% | 156,433 | +12.6% | 0.03% | +16.7% |
Q1 2023 | $12,797,527 | +3.9% | 138,956 | +2.3% | 0.02% | -4.0% |
Q4 2022 | $12,319,423 | +16.4% | 135,789 | -2.5% | 0.02% | +4.2% |
Q3 2022 | $10,583,000 | -9.8% | 139,219 | +0.3% | 0.02% | -7.7% |
Q2 2022 | $11,735,000 | -1.6% | 138,743 | +6.6% | 0.03% | +13.0% |
Q1 2022 | $11,926,000 | +9.2% | 130,133 | +4.3% | 0.02% | +9.5% |
Q4 2021 | $10,918,000 | +12.9% | 124,792 | +5.5% | 0.02% | +5.0% |
Q3 2021 | $9,674,000 | -13.3% | 118,256 | -3.3% | 0.02% | -16.7% |
Q2 2021 | $11,159,000 | +8.7% | 122,273 | +1.9% | 0.02% | -4.0% |
Q1 2021 | $10,269,000 | -17.3% | 120,045 | -8.7% | 0.02% | -24.2% |
Q4 2020 | $12,412,000 | +10.1% | 131,446 | +1.4% | 0.03% | -2.9% |
Q3 2020 | $11,275,000 | -2.1% | 129,624 | -1.6% | 0.03% | -12.8% |
Q2 2020 | $11,515,000 | -1.7% | 131,740 | -42.5% | 0.04% | -18.8% |
Q1 2020 | $11,712,000 | – | 229,306 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |